> top > docs > PMC:7200337 > spans > 51492-51833 > annotations

PMC:7200337 / 51492-51833 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T514 266-274 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T637 29-30 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T638 163-165 http://purl.obolibrary.org/obo/CLO_0001022 denotes Li
T639 163-165 http://purl.obolibrary.org/obo/CLO_0007314 denotes Li
T640 257-258 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T58324 163-165 Chemical denotes Li http://purl.obolibrary.org/obo/CHEBI_30145

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1676 306-308 Gene denotes to Gene:6999

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T283 0-341 Sentence denotes Despite these indications of a successful neutralizing response in the majority of individuals, higher titers are also associated with more severe clinical cases (Li et al., 2020b, Okba et al., 2020, Zhao et al., 2020a, Zhou et al., 2020a), suggesting that a robust antibody response alone is insufficient to avoid severe disease (Figure 4).